Sign in
CompletedPhase 2

A Study of ONO-1110 in Patients With Postherpetic Neuralgia

Key facts

Who runs it
Ono Pharmaceutical Co., Ltd.
Where
Japan31 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 2
People taking part
142 people enrolled
Started
12 Feb 2025
Ended
11 May 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • ONO-1110
  • Placebo
Record updated
15 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Japanese (both sexes)
  • Age (at the time of informed consent): 18 years and older
  • Outpatient
  • Patients with persistent pain ≥3 months (90 days) after the onset of herpes zoster
  • Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)

Who cannot take part

  • Patients who previously underwent neurodestruction or neurosurgical therapy for PHN
  • Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
  • Patients with concurrent psychiatric diseases that may affect assessments in this study
  • Patients with any skin condition related to the site of herpes zoster that may affect assessments in this study
  • Patients with pain other than PHN that may affect assessments in this study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia

The 2 groups in the trial

  • ONO-1110Treatment being tested

    ONO-1110 tablets once a day

  • PlaceboPlacebo, for comparison

    Placebo tablets once daily

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Postherpetic Neuralgia
Record updated
15 July 2026